| Application no. and date | 01113517.5 (espacenet) (Federated) (European Patent Register), 19960626 | | Patent/reg. no. and date | DK/EP 1162272, 20081105 | | Publication date | 20011212 | | Priority no. and date | US 500306, 19950710 | | EP pub. no. and date |
EP 1162272 20011212 | | Effective date | | | Applicant/owner | THE GOVERNMENT OF THE UNITED STATES OF AMERICA,
as represented by the Secretary,
Department of Health and Human Services, 6011 Executive Boulevard,
Suite 325
Office of Technology Transfer
Rockville, MD 20852, US | | Applicant ref. no. | 62678 | | Inventor | Schlom, Jeffrey
National Cancer Institute, 10 Center Drive, Bldg 10, Room 8B09
Bethesda, Maryland 20892, US,
Panicali, Dennis,
Therion Biologics Corporation, 76 Rogers Street
Cambridge, Massachusetts 02142, US | | Representative | Larsen & Birkeholm A/S Skandinavisk Patentbureau, Banegårdspladsen 1, 1570 København V | | Opponent | | | IPC Class | A61K 38/43 (2006.01) , C07K 16/30 (2006.01) , C12N 15/57 (2006.01) , C12N 15/86 (2006.01) , C12N 9/64 (2006.01) | | Title | Frembringelse af immunreaktioner mod prostataspecifikt antigen (SPA) | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
